These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 19653114)
1. Clinical and metabolic risk factor evaluation in young adults with kidney stones. Spivacow FR; Negri AL; del Valle EE; Calviño I; Zanchetta JR Int Urol Nephrol; 2010 Jun; 42(2):471-5. PubMed ID: 19653114 [TBL] [Abstract][Full Text] [Related]
2. Metabolic risk factors in children with kidney stone disease: an update. Spivacow FR; Del Valle EE; Boailchuk JA; Sandoval Díaz G; Rodríguez Ugarte V; Arreaga Álvarez Z Pediatr Nephrol; 2020 Nov; 35(11):2107-2112. PubMed ID: 32564280 [TBL] [Abstract][Full Text] [Related]
3. Metabolic risk factors in children with kidney stone disease. Spivacow FR; Negri AL; del Valle EE; Calviño I; Fradinger E; Zanchetta JR Pediatr Nephrol; 2008 Jul; 23(7):1129-33. PubMed ID: 18324422 [TBL] [Abstract][Full Text] [Related]
4. The ability of a limited metabolic assessment to identify pediatric stone formers with metabolic abnormalities. Chan KH; Moser EA; Whittam BM; Misseri R; Cain MP; Krambeck A J Pediatr Urol; 2018 Aug; 14(4):331.e1-331.e6. PubMed ID: 30177386 [TBL] [Abstract][Full Text] [Related]
5. Stone growth patterns and risk for surgery among children presenting with hypercalciuria, hypocitraturia and cystinuria as underlying metabolic causes of urolithiasis. Zu'bi F; Sidler M; Harvey E; Lopes RI; Hojjat A; Naoum N; Pokarowski M; Lorenzo AJ; Farhat WA; Papanikolaou F; Dos Santos J J Pediatr Urol; 2017 Aug; 13(4):357.e1-357.e7. PubMed ID: 28865885 [TBL] [Abstract][Full Text] [Related]
6. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management. Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910 [No Abstract] [Full Text] [Related]
7. Biochemical diagnosis in 3040 kidney stone formers in Argentina. Spivacow FR; del Valle EE; Negri AL; Fradinger E; Abib A; Rey P Urolithiasis; 2015 Aug; 43(4):323-30. PubMed ID: 25958053 [TBL] [Abstract][Full Text] [Related]
8. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers. Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031 [TBL] [Abstract][Full Text] [Related]
9. [Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal]. Serra A; Domingos F; Salgueiro C; Prata MM Acta Med Port; 2004; 17(1):27-34. PubMed ID: 15636725 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of renal stone disease: metabolic study]. Areses Trapote R; Urbieta Garagorri MA; Ubetagoyena Arrieta M; Mingo Monge T; Arruebarrena Lizarraga D An Pediatr (Barc); 2004 Nov; 61(5):418-27. PubMed ID: 15530322 [TBL] [Abstract][Full Text] [Related]
14. Metabolic risk factors in children with asymptomatic hematuria. Spivacow FR; Del Valle EE; Rey PG Pediatr Nephrol; 2016 Jul; 31(7):1101-6. PubMed ID: 26913725 [TBL] [Abstract][Full Text] [Related]
15. The Modern Metabolic Stone Evaluation in Children. Bevill M; Kattula A; Cooper CS; Storm DW Urology; 2017 Mar; 101():15-20. PubMed ID: 27838366 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology of paediatric renal stone disease: a 22-year single centre experience in the UK. Issler N; Dufek S; Kleta R; Bockenhauer D; Smeulders N; Van't Hoff W BMC Nephrol; 2017 Apr; 18(1):136. PubMed ID: 28420322 [TBL] [Abstract][Full Text] [Related]
20. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]